Description
ARP - Development of rabbit antibodies for the detection of human cancer
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $50,000 at start, $50,000 after amendment #1 (+$0).
- #02018-04-01$50,000
- #12018-11-20$50,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-01(start date) | $50,000 | — | Cancer cells have specific carbohydrate antigens. These markers are absent in healthy cells. Selective antibod… |
| #1 amendment | 2018-11-20 | $50,000 | +$0 | ARP - Development of rabbit antibodies for the detection of human cancer |
Related records · 7
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 747665529)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 093-2024-2025-Q2-00012 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · The Regional Economic Growth Through Innovation Program (REGI) | $250,000 | FY2025 |
| 172-2020-2021-Q2-957295 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $8,477,787 | FY2021 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q1-905044 · retrieved 2026-11-15.